# OPG/Soluble RANKL (sRANKL) and Bone Mineral Density in Primary Hyperparathyroidism

> **NCT01889134** · NA · COMPLETED · sponsor: **Wroclaw Medical University** · enrollment: 112 (actual)

## Conditions studied

- Primary Hyperparathyroidism

## Interventions

- **DRUG:** Sedron (alendronate)
- **PROCEDURE:** Parathyroidectomy

## Key facts

- **NCT ID:** NCT01889134
- **Lead sponsor:** Wroclaw Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2012-06
- **Final completion:** 2012-10
- **Target enrollment:** 112 (ACTUAL)
- **Last updated:** 2013-06-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01889134

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01889134, "OPG/Soluble RANKL (sRANKL) and Bone Mineral Density in Primary Hyperparathyroidism". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01889134. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*